Chris RUNDFELDT,Rita DOST,Wolfgang LOSCHER,Andrea TIPOLD,Klaus UNVERFERTH,Hans-Joachim LANKAU
申请号：
US15251022
公开号：
US20160367562A1
申请日:
2016.08.30
申请国别(地区):
US
年份:
2016
代理人:
摘要：
The present invention relates to the use of substituted dihydroimidazolones, particularly [1-(4-Chlorophenyl)-4-(4-morpholinyl)-2,5-dihydro-1H-imidazol-2-one] (AWD 131-138) or a physiologically acceptable salt thereof for the treatment of epilepsy in dogs.
